Progress in enzyme replacement therapy in glycogen storage disease type II.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 3, p. 143, doi. 10.1177/1756285609103324
- By:
- Publication type:
- Article
Works matching IS 17562856 AND DT 2009 AND VI 2 AND IP 3
Results: 5
1
2
Fixed-dose sumatriptan/naproxen sodium compared with each monotherapy utilizing the novel composite endpoint of sustained pain-free/no adverse events.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 3, p. 135, doi. 10.1177/1756285609102769
- By:
- Publication type:
- Article
3
Review: Therapy for Alzheimer's disease: how effective are current treatments?
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 3, p. 163, doi. 10.1177/1756285609102724
- By:
- Publication type:
- Article
4
Review: Drug and nondrug treatment in tension-type headache.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 3, p. 155, doi. 10.1177/1756285609102328
- By:
- Publication type:
- Article
5
Review: Comparing drug treatments in epilepsy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 3, p. 181, doi. 10.1177/1756285609102327
- By:
- Publication type:
- Article